T1	Measurement 10 34	gestational age at birth
T2	Value 0 9	=32 weeks
R1	Has_value Arg1:T1 Arg2:T2	
T3	Measurement 45 58	postnatal age
T4	Temporal 59 75	at randomization
T5	Value 36 44	=6 weeks
R2	Has_value Arg1:T3 Arg2:T5	
R3	Has_temporal Arg1:T3 Arg2:T4	
T6	Observation 85 97	hospitalized
T7	Temporal 98 109	after birth
T8	Reference_point 104 109	birth
R4	Has_index Arg1:T7 Arg2:T8	
R5	Has_temporal Arg1:T6 Arg2:T7	
T9	Mood 176 184	eligible
T10	Drug 196 212	2-month vaccines
R6	Has_mood Arg1:T10 Arg2:T9	
T11	Non-query-able 214 298	English- or Spanish-speaking parent(s)/legally authorized representative(s) (LAR(s))
T12	Mood 304 311	planned
T13	Procedure 316 325	discharge
T14	Temporal 326 356	within 60 hours of study entry
T15	Reference_point 345 356	study entry
T16	Measurement 300 303	Not
R8	Has_mood Arg1:T13 Arg2:T12	
R9	Has_temporal Arg1:T13 Arg2:T14	
R7	AND Arg1:T13 Arg2:T16	
T17	Informed_consent 358 505	The parent/guardian must be willing and capable of providing permission for their child to participate through the written informed consent process
